160 related articles for article (PubMed ID: 11128035)
1. Involvement of the renal kallikrein-kinin system in furosemide-induced natriuresis in rats.
Fujita T; Kumagai Y; Ikeda Y; Inamura N; Iwata T; Ogino M; Majima M
Jpn J Pharmacol; 2000 Oct; 84(2):133-9. PubMed ID: 11128035
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the renal kallikrein-kinin system in K(+)-induced diuresis and natriuresis in anesthetized rats.
Suzuki T; Katori M; Fujita T; Kumagai Y; Majima M
Eur J Pharmacol; 2000 Jul; 399(2-3):223-7. PubMed ID: 10884523
[TBL] [Abstract][Full Text] [Related]
3. Oxytocin-induced natriuresis mediated by the renal kallikrein-kinin system in anesthetized male rats.
Adachi K; Majima M; Katori M; Nishijima M
Jpn J Pharmacol; 1995 Mar; 67(3):243-52. PubMed ID: 7630042
[TBL] [Abstract][Full Text] [Related]
4. Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.
Ayano Y; Yamasaki K; Soejima H; Ikegami K
Urol Int; 1984; 39(1):52-7. PubMed ID: 6587655
[TBL] [Abstract][Full Text] [Related]
5. Relationship of urinary kallikrein excretion to urinary potassium excretion during furosemide administration with and without amiloride.
Obika LF
Arch Int Physiol Biochim; 1987 Mar; 95(1):13-8. PubMed ID: 2441670
[TBL] [Abstract][Full Text] [Related]
6. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
Schnackenberg CG; Merz E; Brooks DP
Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
[TBL] [Abstract][Full Text] [Related]
7. Renal kallikrein-kinin system, but not renal dopamine system, mediates the natriuretic response to intravenous saline infusion in healthy Chinese subjects.
Chan TY; Critchley JA; Ho CS; Tomlinson B; Chan JC; Poon EW; Lee ZS; Critchley LA; Swaminathan R
J Auton Pharmacol; 2000 Feb; 20(1):37-45. PubMed ID: 11048960
[TBL] [Abstract][Full Text] [Related]
8. Amiloride, frusemide and urinary kallikrein excretion.
Waller DG; Thakrar PM; Campbell SK
Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):145-50. PubMed ID: 3446039
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of the novel highly potent diuretic 7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid potassium salt.
Shinkawa T; Yamasaki F; Kikuchi A; Nakakuki M; Nishijima K; Uemura A; Mizota M; Orita Y
Arzneimittelforschung; 1992 Dec; 42(12):1466-72. PubMed ID: 1337698
[TBL] [Abstract][Full Text] [Related]
10. Non-natriuretic doses of furosemide: potential use for decreasing the workload of the renal outer medulla with minimal magnesium wasting in the rat.
Kim N; Cheema-Dhadli S; Hare GM; Chong CK; Halperin ML; Kamel KS; Mazer CD
Nephron Physiol; 2012; 122(1-2):7-12. PubMed ID: 23548701
[TBL] [Abstract][Full Text] [Related]
11. Interference of different ACE-inhibitors with the diuretic action of furosemide and hydrochlorothiazide.
Toussaint C; Masselink A; Gentges A; Wambach G; Bönner G
Klin Wochenschr; 1989 Nov; 67(22):1138-46. PubMed ID: 2586018
[TBL] [Abstract][Full Text] [Related]
12. An ATP-sensitive potassium channel blocker suppresses sodium-induced hypertension through increased secretion of urinary kallikrein.
Kamata Y; Fujita T; Kato T; Hayashi I; Kurosaka M; Katori M; Fujita Y; Majima M
Hypertens Res; 2009 Mar; 32(3):220-6. PubMed ID: 19262486
[TBL] [Abstract][Full Text] [Related]
13. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
[TBL] [Abstract][Full Text] [Related]
14. [Kidney kallikrein-kinin system in different mechanisms of diuresis].
Zharova EA; Sokolova RI; Nekrasova AA
Biull Eksp Biol Med; 1977 Aug; 84(8):141-3. PubMed ID: 907812
[TBL] [Abstract][Full Text] [Related]
15. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
[TBL] [Abstract][Full Text] [Related]
16. Activation of purinergic receptors (P2) in the renal medulla promotes endothelin-dependent natriuresis in male rats.
Gohar EY; Speed JS; Kasztan M; Jin C; Pollock DM
Am J Physiol Renal Physiol; 2016 Aug; 311(2):F260-7. PubMed ID: 27226106
[TBL] [Abstract][Full Text] [Related]
17. Kinin antagonist blunts the diuretic effect of furosemide in deoxycorticosterone-treated rats.
Madeddu P; Glorioso N; Pinna Parpaglia P; Demontis MP; Varoni MV; Fattaccio MC; Sabino G; Pisanu G; Patteri G; Anania V
Agents Actions Suppl; 1992; 38 ( Pt 3)():156-62. PubMed ID: 1462856
[TBL] [Abstract][Full Text] [Related]
18. [The saluretic effect of xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylilide) in normal subjects].
Hempelmann FW; Leuschner F; Liebenow W
Arzneimittelforschung; 1975 Feb; 25(2):252-5. PubMed ID: 1173042
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ROMK blocks macula densa tubuloglomerular feedback yet causes renal vasoconstriction in anesthetized rats.
Araujo M; Welch WJ; Zhou X; Sullivan K; Walsh S; Pasternak A; Wilcox CS
Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1120-F1127. PubMed ID: 28228405
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological analysis of the action of diuretics in the newborn pig.
Noordewier B; Bailie MD; Hood JB
J Pharmacol Exp Ther; 1978 Oct; 207(1):236-42. PubMed ID: 702345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
